Home › Bile Duct Cancer (Cholangiocarcinoma) › Maryland › Baltimore
Bile Duct Cancer (Cholangiocarcinoma) clinical trials in Baltimore, MD
5 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- United Theranostics, Glen Burnie · 9 mi away
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- The John Hopkins Hospital, Baltimore
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
RecruitingPhase 1
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi away
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Recruiting
- The Johns Hopkins Hospital, Baltimore
Bile Duct Cancer (Cholangiocarcinoma) trials in other cities
- Houston, TX13 studies
- New York City, NY11 studies
- Boston, MA8 studies
- Rochester, MN7 studies
- Arlington, VA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Columbus, OH6 studies
- Cleveland, OH6 studies
- Edison, NJ5 studies
- Queens, NY5 studies
- Grand Rapids, MI5 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Pancreatic Cancer31 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity26 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Ovarian Cancer22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.